Different comparison of mean SR. homocystene in serum 25 – hydroxyvitamin D in acute stroke

Sahu Padmini; Y. P. Sahu; Marndi Gujaram; Pravin G. Dhone

doi:10.53730/ijhs.v6nS5.10037

Different comparison of mean SR. homocystene in serum 25 – hydroxyvitamin D in acute stroke

https://doi.org/10.53730/ijhs.v6nS5.10037

Authors

Sahu Padmini Assistant Professor, Department of Surgery, Bhima Bhoi Medical College and Hospital, Balangir
Sahu Y. P. Assistant Professor, Department of Pharmacology VIMSAR, Burla
Marndi Gujaram Associate professor, Department of Pharmacology, GMC&H, Keonjhar
Dhone Pravin G.* Professor & Head, Department of Pharmacology, RSDKS GMC, Ambikapur

Keywords:

serum 25, hydroxyvitamin D, homocysteine, stroke

Abstract

The active form of vitamin D is 1,25 dihydroxy vitamin D. Renal and many extra renal tissues are able to synthesize 1,25 dihydroxy vitamin D on a local and intracellular level. Local tissue level of 1,25 di-hydroxyvitamin D is determined by concentration of circulating 25(OH) vitamin D level. Stroke is a common worldwide health problem. It is a major cause of morbidity, mortality and disability in developed as well as developing countries. Both vitamin D deficiency and stroke are very common in urban and rural India. Hence this study was designed to evaluate the association of vitamin D deficiency in acute stroke. This study shows the different comparison of MEAN SR. HOMOCYSTENE in serum 25 – hydroxyvitamin D in acute stroke and found to be in total serum homocysteine levels were 19.64 micro mole/l in cases than 10.1 in control However the difference was statistically highly significant (p<.0002).

Downloads

Download data is not yet available.

References

GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the

Global Burden of Disease Study 2013. Lancet 385: 117–71. doi:10.1016/S0140-6736(14)61682-2 . PMC 4340604

Jeyraj durai pandian, Paulin sudhan; stroke epidemiology and stroke care services in India, journal of stroke 11,137-138(2013)

Hugh S, Markus-An introduction to stroke Aho K, Harmsen P, H atano S, Smirnov VE. Cerebrovascular disease in community: results of WHO collaborative study. Bull world Health Organ 1980; 58:113-30

Sun Q, Pan A, Hu FB, Manson JE, Rexored KM-25HYDROXYVITAMIN D level and risk of stroke, A prospective study and meta-analysis, Stroke 2012:43,1470-7

Brondum jacobson P, Nordestagaard BG, Schnohr P ,25 Hydroxyvitamin D and symptomatic ischemic stroke; an original study and meta-analysis 2013;38-47

Brewer L C , Michos E D. Vitamin D in atherosclerosis and vascular disease, Current drug target 2011;12:54-60

Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006; 116:2062–72

Muscogiuri G. Vitamin D: past, present and future perspectives in the prevention of chronic diseases. Eur J Clin Nutr. 2018;72: 1221–5

Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014; 2:76–89

Grant WB. Review of recent advances in understanding the role of vitamin D in reducing cancer risk: breast, colorectal, prostate, and overall cancer. Anticancer Res. 2020; 40:491–9

Moreno LA, Valtueña J, Pérez-López F, González-Gross M. Health effects related to low vitamin D concentrations: beyond bone metabolism. Ann Nutr Metab. 2011; 59:22–7

Dirks NF, Ackermans MT, Lips P, de Jongh RT, Vervloet MG, de Jonge R, et al. The when, what & how of measuring vitamin D metabolism in clinical medicine. Nutrients 2018;10:482.

Published

30-06-2022

How to Cite

Padmini, S., Sahu, Y. P., Gujaram, M., & Dhone, P. G. (2022). Different comparison of mean SR. homocystene in serum 25 – hydroxyvitamin D in acute stroke. International Journal of Health Sciences, 6(S5), 5454–5461. https://doi.org/10.53730/ijhs.v6nS5.10037

Download Citation

Issue

Vol. 6 No. S5 (2022)

Section

Peer Review Articles

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.